» Articles » PMID: 32870141

Nightmare Recurrence in Patients with Post-traumatic Stress Disorder is Likely a Primary Feature of Central Sympathetic Nervous Activation

Overview
Specialties Neurology
Psychiatry
Date 2020 Sep 2
PMID 32870141
Authors
Affiliations
Soon will be listed here.
References
1.
Morgenthaler T, Auerbach S, Casey K, Kristo D, Maganti R, Ramar K . Position Paper for the Treatment of Nightmare Disorder in Adults: An American Academy of Sleep Medicine Position Paper. J Clin Sleep Med. 2018; 14(6):1041-1055. PMC: 5991964. DOI: 10.5664/jcsm.7178. View

2.
Gupta M . Spontaneous reporting of onset of disturbing dreams and nightmares related to early life traumatic experiences during the COVID-19 pandemic by patients with posttraumatic stress disorder in remission. J Clin Sleep Med. 2020; 16(8):1419-1420. PMC: 7446081. DOI: 10.5664/jcsm.8562. View

3.
Sierro C, Leslie W, Putois B . Long-term effects of treatment for chronic nightmares: is imagery rehearsal therapy robust in the COVID-19 pandemic?. J Clin Sleep Med. 2020; 16(11):1993. PMC: 8034210. DOI: 10.5664/jcsm.8742. View